Falah S Al-Fartusie, Safaa I Kader, Sara Jassim Mohammed, Fahim Muhsin Mahmood, Anwar A Algaber, Majeed N Farhan
{"title":"Comparison of Serum Zn, Cu, Mg, Mn, Cr, and Fe Levels in Iraqi COVID-19 Patients and their Association with Infection Severity.","authors":"Falah S Al-Fartusie, Safaa I Kader, Sara Jassim Mohammed, Fahim Muhsin Mahmood, Anwar A Algaber, Majeed N Farhan","doi":"10.1007/s12291-024-01254-4","DOIUrl":null,"url":null,"abstract":"<p><p>An ideal level of vital trace elements (TE) is crucial for the immune system to protect organs from infections. TE, in particular, zinc (Zn), copper (Cu), magnesium (Mg), manganese (Mn), chromium (Cr), and iron (Fe), affect an individual's sensitivity to the exposure and progression of viral diseases, such as COVID-19. Therefore, this study evaluated the level of these TE during hospitalization in an isolation center and investigated their association with the severity of COVID-19. This study included 118 individuals, 63 male and 55 female aged between 20 and 60 years. Seventy-eight COVID-19 patients and 40 healthy individuals were included in this study. Infected individuals were classified into moderate and severe based on the severity of their symptoms. The levels of Zn, Mg, Mn, Cr, and Fe were significantly decreased in moderate and severe groups compared to the controls (<i>p</i> < 0.0001), respectively. Conversely, levels of Cu were found significantly increasing compared to individuals in the control's groups (<i>p</i> < 0.0001). Among the total number of infected cases, the levels of Zn, Cu, Mn, Cr, and Fe did not significantly increase with increasing severity (from moderate to severe). The findings indicated that TE levels were not altered in a severity-dependent manner, showing that TE affect the individual's vulnerability to COVID-19, not its progression.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12291-024-01254-4.</p>","PeriodicalId":13280,"journal":{"name":"Indian Journal of Clinical Biochemistry","volume":"41 2","pages":"267-276"},"PeriodicalIF":1.6000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12988099/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Clinical Biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12291-024-01254-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/6 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
An ideal level of vital trace elements (TE) is crucial for the immune system to protect organs from infections. TE, in particular, zinc (Zn), copper (Cu), magnesium (Mg), manganese (Mn), chromium (Cr), and iron (Fe), affect an individual's sensitivity to the exposure and progression of viral diseases, such as COVID-19. Therefore, this study evaluated the level of these TE during hospitalization in an isolation center and investigated their association with the severity of COVID-19. This study included 118 individuals, 63 male and 55 female aged between 20 and 60 years. Seventy-eight COVID-19 patients and 40 healthy individuals were included in this study. Infected individuals were classified into moderate and severe based on the severity of their symptoms. The levels of Zn, Mg, Mn, Cr, and Fe were significantly decreased in moderate and severe groups compared to the controls (p < 0.0001), respectively. Conversely, levels of Cu were found significantly increasing compared to individuals in the control's groups (p < 0.0001). Among the total number of infected cases, the levels of Zn, Cu, Mn, Cr, and Fe did not significantly increase with increasing severity (from moderate to severe). The findings indicated that TE levels were not altered in a severity-dependent manner, showing that TE affect the individual's vulnerability to COVID-19, not its progression.
Supplementary information: The online version contains supplementary material available at 10.1007/s12291-024-01254-4.
期刊介绍:
The primary mission of the journal is to promote improvement in the health and well-being of community through the development and practice of clinical biochemistry and dissemination of knowledge and recent advances in this discipline among professionals, diagnostics industry, government and non-government organizations. Indian Journal of Clinical Biochemistry (IJCB) publishes peer reviewed articles that contribute to the existing knowledge in all fields of Clinical biochemistry, either experimental or theoretical, particularly deal with the applications of biochemistry, molecular biology, genetics, biotechnology, and immunology to the diagnosis, treatment, monitoring and prevention of human diseases. The articles published also include those covering the analytical and molecular diagnostic techniques, instrumentation, data processing, quality assurance and accreditation aspects of the clinical investigations in which chemistry has played a major role, or laboratory animal studies with biochemical and clinical relevance.